Discover
VVOS
Vivos Therapeutics, Inc.
0.15
1 x 0.15
1 x 0.15
bid
ask
-
0.00
0.40%
1 @ 07:03 PM
0.15 -0.00 (1.95%)
| Ytd | -92.67% | |
| 1y | -95.24% |
0.14
day range
0.16
0.13
52 week range
3.18
| Open | 0.15 | Prev Close | 0.15 | Low | 0.14 | High | 0.16 | Mkt Cap | 5.00M |
| Vol | 8.83M | Avg Vol | 12.57M | EPS | -1.88 | P/E | N/A | Forward P/E | -9.31 |
| Beta | 7.68 | Short Ratio | 0.66 | Inst. Own | 13.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 0.23 | 200-d Avg | 0.90 | 1yr Est | 6.30 |
| Income Statement | |||
| Total Revenue | 5.15M | ||
| Revenues (USD) | 5.15M | ||
| Cost of Revenue | 2.20M | ||
| Gross Profit | 2.95M | ||
| Operating Expenses | 7.78M | ||
| Selling, General and Administrative Expense | 7.27M | ||
| Operating Income | -4.82M | ||
| Net Income | -5.48M | ||
| Net Income Common Stock | -5.48M | ||
| Net Income Common Stock (USD) | -5.48M | ||
| Consolidated Income | -5.52M | ||
| Net Income to Non-Controlling Interests | -42.00K | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -5.48M | ||
| Earning Before Interest & Taxes (USD) | -5.48M | ||
| Weighted Average Shares | 17.68M | ||
| Weighted Average Shares Diluted | 17.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.77M | ||
| Cash and Equivalents (USD) | 1.77M | ||
| Trade and Non-Trade Receivables | 1.44M | ||
| Current Assets | 4.21M | ||
| Property, Plant & Equipment Net | 7.45M | ||
| Total Assets | 24.14M | ||
| Debt Current | 8.62M | ||
| Total Debt | 12.51M | ||
| Current Liabilities | 20.39M | ||
| Debt Non-Current | 3.89M | ||
| Total Liabilities | 28.13M | ||
| Accumulated Retained Earnings (Deficit) | -138.52M | ||
| Shareholders Equity | -3.81M | ||
| Shareholders Equity (USD) | -3.81M | ||
| Assets Non-Current | 19.93M | ||
| Total Debt (USD) | 12.51M | ||
| Deferred Revenue | 583.00K | ||
| Goodwill and Intangible Assets | 12.21M | ||
| Liabilities Non-Current | 7.74M | ||
| Trade and Non-Trade Payables | 2.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 511.00K | ||
| Net Cash Flow from Financing | 3.23M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -336.00K | ||
| Capital Expenditure | -416.00K | ||
| Issuance (Purchase) of Equity Shares | 839.00K | ||
| Issuance (Repayment) of Debt Securities | 797.00K | ||
| Net Cash Flow from Investing | -416.00K | ||
| Net Cash Flow from Operations | -3.15M | ||
| Share Based Compensation | 50.00K | ||